Wird geladen...
Decreased bronchodilating effect of salbutamol in relieving methacholine induced moderate to severe bronchoconstriction during high dose treatment with long acting β(2) agonists
BACKGROUND—In vitro the long acting β(2) agonist salmeterol can, in contrast to formoterol, behave as a partial agonist and become a partial antagonist to other β(2) agonists. To study this in vivo, the bronchodilating effect of salbutamol was measured during methacholine induced moderate to severe...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BMJ Group
2001
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1746085/ https://ncbi.nlm.nih.gov/pubmed/11413351 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/thorax.56.7.529 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|